Wound Debridement Products: Market Research Report

December 2018 | 165 pages | ID: W044A12336AEN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Wound Debridement Products in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2016 through 2024.

Also, a five-year historic analysis is provided for these markets.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 29 companies including many key and niche players such as -

• Advanced Medical Solutions Group plc
• Coloplast A/S
• DeRoyal Industries, Inc.
• Derma Sciences, Inc.
• Lohmann & Rauscher GmbH
• Misonix, Inc.

Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Wound Debridement Products

2. INDUSTRY OVERVIEW

Wound Debridement – Market Overview
Various Debridement Methods Available
Current and Future Analysis
Competition
Leading Players in the Global Wound Debridement Products Market by Segment
Chronic Wounds and Healthcare Burden
Chronic Wounds Statistics
Prevalence of Wounds – Select Statistics

Table 1. Global Prevalence of Wounds (2017) (includes corresponding Graph/Chart)

Table 2. Global Wound Care Market (2017): Percentage Breakdown of Spending by Wound Type (includes corresponding Graph/Chart)

Table 3. Healing Time by Type of Wound (in Days)

Table 4. Incidence of Open Wounds in Select Countries (2013) (includes corresponding Graph/Chart)

Growing Incidence of Hard-to-Heal Wounds, and Increased Wound Care Costs Drive Debridement Products Market

Table 5. Breakdown of Costs Associated with Wound Care (includes corresponding Graph/Chart)

Diabetic Foot Ulcers - An Critical Area for Wound Debridement Products
Rise in Prevalence of Pressure Ulcers and the Growing Focus on Treatment Solutions

Table 6. Pressure Ulcer Occurrence Rate Based on the Length of Surgery (includes corresponding Graph/Chart)

Maintenance Debridement Sustains Adoption of Debridement Products/Techniques

3. MARKET TRENDS AND DRIVERS

Santyl – The Leading Enzymatic Debridement Agent
Monofilament Polyester Fibre Pads Buoy Growth in Mechanical Debridement Market
Hydrosurgery Emerges as a Safe and Cost Effective Method
Micro Water Jet Technology (MWT) – Highly Efficient Means of Debridement
Robotic MWT
Ultrasound Emerges as a Viable Option to Promote Improved Wound Healing
SonicOne for Ultrasonic Debridement
Honey as a Debridement Agent Gains Prominence
Larvae Therapy Re-Emerges as an Effective Debridement Technology
Plasma-Mediated Bipolar Radio Frequency Ablation Demonstrates Selective Ablation
CPI Wound Therapy System Enables Bedside Pressurized Irrigation
Jetox Lavage Systems

4. MACRO GROWTH DRIVERS

Expanding Aging Population Spurs Demand

Table 7. Elderly Population (60+ Years) as a Percentage of the Total Population: 2012 & 2050 (includes corresponding Graph/Chart)

Table 8. Global Population Statistics for 65+ Age Group (Male & Female) for Major Countries/Regions (mid-2016) (includes corresponding Graph/Chart)

Table 9. Life Expectancy for Select Countries in Number of Years: 2015 (includes corresponding Graph/Chart)

Rising Prevalence of Diabetes Escalates Incidence of Chronic Wounds

Table 10. Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045 (includes corresponding Graph/Chart)

Table 11. Global Prevalence of Diabetes - Number of Adults Diagnosed with Diabetes (in Million) by Gender for the Year 2017 (includes corresponding Graph/Chart)

Table 12. Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender for the Year 2017 (includes corresponding Graph/Chart)

Table 13. Diabetes Prevalence in Rural and Urban Areas - Number of Adults with Diagnosed Diabetes (in Million) in Urban and Rural Areas for 2017 and 2045 (includes corresponding Graph/Chart)

Table 14. Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2017 and 2045 (includes corresponding Graph/Chart)

Table 15. Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region for the Year 2017 (includes corresponding Graph/Chart)

Increasing Obesity Levels Underpins Market Growth

Table 16. World Obesity Prevalence (2015 & 2022): Percentage of Obese Population for Leading Ten Countries (includes corresponding Graph/Chart)

Hospital Acquired Infections Boost Demand

5. PRODUCT OVERVIEW

Debridement
Purpose of Debridement
Factors Influencing Debridement Decision
Methods/Techniques of Debridement
Autolytic Debridement
Biologic Debridement
Chemical/Enzymatic Debridement
Mechanical Debridement
Surgical Debridement
Ultrasound
Types of Wounds
Acute Wounds
Surgical Incisions
Burns
Chemical Burns
Electrical Burns
Flash Burns
Radiation Burns
Thermal Burns
Chronic Wounds
Diabetic Ulcers
Venous Ulcers
Pressure Ulcers
Process of Wound Care
Preparation
Controlling Bleeding
Irrigation and Cleaning
Closure
Infection Control
Wound Healing Process
Injury
Inflammatory Response
Characteristics
Coagulation Cascade
Vasodilation
Cellular Activity
Debridement, Cell Growth and Healing
Scarring
Abnormal Scarring
Fetal Wound Healing

6. COMPETITIVE LANDSCAPE

6.1 Focus on Select Global Players
Advanced Medical Solutions Group plc (UK)
Coloplast A/S (Denmark)
DeRoyal Industries, Inc.
Derma Sciences, Inc. (USA)
Lohmann & Rauscher GmbH (Germany)
Misonix, Inc. (USA)
MediWound Ltd. (Israel)
Medline Industries, Inc. (USA)
Smith & Nephew Plc (UK)
Soering GmbH (Germany)
Welcare Industries SpA (Italy)
Zimmer Biomet Holdings, Inc. (USA)
6.2 Recent Industry Activity
MediWound Receives Additional Award Contract from BARDA to Develop NexoBrid for Sulfur Mustard Injuries
MediWound Receives Marketing Authorization for NexoBrid in Russia
MediWound Announces the Expansion of NexoBrid Phase 3 Children Innovation Debridement Study (CIDS) to the U. S.
MediWound Completes Enrollment of NexoBrid’s Phase 3 DETECT Study in U. S.
MediWound Receives Marketing Authorization for NexoBrid in South Korea
B. Braun Introduces 1-Ounce Prontosan Wound Gel X
MediWound Signs New Distribution Agreement with Holy Stone Healthcare
MediWound Completes U. S. Phase 3 DETECT Study Enrollment for NexoBrid
MediWound Completes Second Cohort of EscharEx Phase 2 Study
MPP Group Introduces Dextranomer-Based Advanced Wound Care Products
Integra LifeSciences Acquires Derma Sciences Inc.
Lohmann & Rauscher Introduces Debrisoft Lolly
Misonix Introduces SonicVac based on LFDCU Debridement Technology
Topigenix Launches Topigenix Wound Care Line
EscharEx from MediWound Completes Phase II Clinical Trial

7. GLOBAL MARKET PERSPECTIVE

Table 17. World Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 18. World Historic Review for Wound Debridement Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 19. World 14-Year Perspective for Wound Debridement Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)

8. REGIONAL MARKET PERSPECTIVE

8.1 The United States
A. Market Analysis
Ageing Demographics and Rising Chronic Disease Incidence Drive Market Growth

Table 20. North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)

Table 21. Prevalence of Hard-to-Heal Chronic Wounds in the US (2017): Percentage Breakdown of Share by Type (includes corresponding Graph/Chart)

High Prevalence of Diabetes Drive Growth in Debridement Procedures

Table 22. Diabetes Prevalence in the US: Number of Patients in 000’s (2010-2017E) (includes corresponding Graph/Chart)

Table 23. Diabetes Prevalence in the US (2017): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart)

Table 24. Diabetes Prevalence in the US (2017): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart)

Table 25. Diabetes Prevalence by Ethnicity (2015) (includes corresponding Graph/Chart)

Rising Incidence of Pressure Ulcers Drives Demand for Wound Debridement Products

Table 26. Pressure Ulcer Incidence and Prevalence in the US by Setting

Table 27. Prevalence of Chronic Wounds in the Medicare Population (includes corresponding Graph/Chart)

Alarming Rise in Obesity to Drive Demand

Table 28. The US Adult Population by Weight Category: 2011-2015 (includes corresponding Graph/Chart)

Table 29. The US Adult Obesity Prevalence by Class (2011-2015): Percentage of Adult Population for Class I, Class II and Class III (includes corresponding Graph/Chart)

Medicare Reimbursement

2018 NATIONAL MEDICARE REIMBURSEMENT RATES

Table 30. Debridement Codes - Hospital Outpatient/Ambulatory Surgical Center Setting

Table 31. Debridement Codes - Physician Service – Facility or Non-Facility Setting

Table 32. Active Wound Care Management - Hospital Outpatient/Ambulatory Surgical Center Setting

B. Market Analytics

Table 33. The US Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 34. The US Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

8.2 Canada
A. Market Analysis
Rising Wound Incidence in Canada – A Key Growth Driver

Table 35. Wound Prevalence in Canada (%) in (2012) (includes corresponding Graph/Chart)

Diabetes Statistics in Canada: An Opportunity Indicator

Table 36. Diabetes Statistics in Canada (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s)

B. Market Analytics

Table 37. Canadian Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 38. Canadian Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

8.3 Japan
A. Market Analysis
Aging Population to Drive Opportunities

Table 39. Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)

Rising Incidence of Chronic Diseases – A Key Growth Driver

Table 40. Diabetes Statistics in Japan (2017) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), and Number of Diabetes- Related Deaths (in ‘000s)

B. Market Analytics

Table 41. Japanese Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 42. Japanese Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

8.4 Europe
A. Market Analysis
High Wound Prevalence – A Strong Growth Driver

Table 43. Prevalence of Chronic Wounds in Europe (2017): Percentage Breakdown of Share by Type (includes corresponding Graph/Chart)

Diabetes Statistics in Europe

Table 44. Diabetes and Population Statistics in Europe (2017 & 2045) (includes corresponding Graph/Chart)

Table 45. Diabetes Statistics in Europe (2017) - Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years) for Select Countries (includes corresponding Graph/Chart)

B. Market Analytics

Table 46. European Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 47. European Historic Review for Wound Debridement Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 48. European 14-Year Perspective for Wound Debridement Products by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)

8.5 Asia-Pacific
A. Market Analysis
Rise in Incidence of Diabetes Mellitus Drives Market Growth

Table 49. Diabetes and Population Statistics in Western Pacific (2017 & 2045) (includes corresponding Graph/Chart)

Table 50. Diabetes and Population Statistics in South East Asia (2017 & 2045) (includes corresponding Graph/Chart)

B. Market Analytics

Table 51. Asia-Pacific Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 52. Asia-Pacific Historic Review for Wound Debridement Products by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 53. Asia-Pacific 14-Year Perspective for Wound Debridement Products by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)

8.6 Latin America
A. Market Analysis
Diabetes Statistics in Latin America

Table 54. Diabetes and Population Statistics in South & Central America (2017 & 2045) (includes corresponding Graph/Chart)

Table 55. Diabetes Statistics in South & Central America (2017) - Number of Adults with Diabetes (20-79 (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

B. Market Analytics

Table 56. Latin American Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 57. Latin American Historic Review for Wound Debridement Products by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 58. Latin American 14-Year Perspective for Wound Debridement Products by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)

8.7 Rest of World
A. Market Analysis
Rise in Incidence of Chronic Conditions Offers Positive Growth Prospects

Table 59. Diabetes and Population Statistics in Middle East and North Africa for 2017 and 2045 (includes corresponding Graph/Chart)

Diabetes Statistics Africa

Table 60. African Diabetes and Population Statistics (2017 & 2045) (includes corresponding Graph/Chart)

Table 61. Diabetes Statistics in Middle East and North Africa (2017) - Number of Adults with Diabetes (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed diabetes (20-79) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Key Opportunity Indicator: Aging Population

Table 62. Aging Population in the Middle East by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 63. Rest of World Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 64. Rest of World Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

9. COMPANY PROFILES

Total Companies Profiled: 29 (including Divisions/Subsidiaries - 36)
The United States (24)
Canada (1)
Europe (9)
  Germany (4)
  The United Kingdom (3)
  Italy (1)
  Rest of Europe (1)
Asia-Pacific (Excluding Japan) (1)
Middle East (1)